352
Participants
Start Date
June 3, 2019
Primary Completion Date
October 28, 2019
Study Completion Date
January 29, 2020
SB206 12%
Topically once daily
Placebo
Topically once daily
Site #308, Silver Spring
Site #285, Lynchburg
Site #279, Greensboro
Site #259, Charleston
Site #295, Fountain Inn
Site #116, Newnan
Site #286, Miami Lakes
Site #287, Boca Raton
Site #264, Miami
Site #273, West Palm Beach
Site #218, Mobile
Site #291, Kingsport
Site #117, Louisville
Site #270, Dublin
Site #251, Indianapolis
Site #288, Evansville
Site #243, Clinton Township
Site #280, Chicago
Site #289, Metairie
Site #219, Monroe
Site #298, Little Rock
Site #272, Rogers
Site #252, Norman
Site #299, Longview
Site #269, Katy
Site #224, San Antonio
Site #183, Austin
Site #302, Boise
Site #277, Salt Lake City
Site #312, Glendale
Site #140, Lomita
Site #237, Gresham
Site #303, Jacksonville
Site #296, Beverly
Site #311, Warwick
Synteract, Inc.
INDUSTRY
Novan, Inc.
INDUSTRY